Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
Appointed CFO
|
|
GILEAD SCIENCES, INC. (GILD)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2023 |
4
| Patterson Sandra (SVP, Controllership) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Paid exercise price by delivering 1,306 shares
@ $80, valued at
$104.5k
Exercised 4,484 restricted stock units
@ $0 |
|
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2023 |
4
| Lofton Kevin E (Director) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Granted 31 options to buy
@ $0 |
|
| 06/30/2023 |
4
| GILEAD SCIENCES, INC. (10% Owner) has filed a Form 4 on Arcus Biosciences, Inc.|
Txns:
| Bought 1,010,000 shares
@ $19.26, valued at
$19.5M
|
|
| 06/28/2023 |
4
| GILEAD SCIENCES, INC. (10% Owner) has filed a Form 4 on Allovir, Inc.|
Txns:
| Bought 2,930,870 shares
@ $3.75, valued at
$11M
|
|
| 06/12/2023 |
4
| Patterson Sandra (SVP, Controllership) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Paid exercise price by delivering 153 shares
@ $78.12, valued at
$12k
Exercised 517 restricted stock units
@ $0 |
|
| 06/12/2023 |
4
| Parsey Merdad (Chief Medical Officer) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Paid exercise price by delivering 1,294 shares
@ $78.12, valued at
$101.1k
Exercised 2,779 restricted stock units
@ $0 |
|
| 06/12/2023 |
4
| O'Day Daniel Patrick (Chairman & CEO) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Paid exercise price by delivering 3,409 shares
@ $78.12, valued at
$266.3k
Exercised 7,346 restricted stock units
@ $0 |
|
| 06/12/2023 |
4
| Mercier Johanna (Chief Commercial Officer) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Paid exercise price by delivering 1,272 shares
@ $78.12, valued at
$99.4k
Exercised 2,730 restricted stock units
@ $0 |
|
| 06/12/2023 |
4
| Dickinson Andrew D (CFO) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Paid exercise price by delivering 1,219 shares
@ $78.12, valued at
$95.2k
Exercised 2,618 restricted stock units
@ $0 |
|
| 05/04/2023 |
4
| Kramer Kelly A. (Director) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Granted 1,887 restricted stock units
@ $0
Granted 10,173 options to buy
@ $79.45, valued at
$808.2k
|
|
| 05/04/2023 |
4
| BARTON JACQUELINE K (Director) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Granted 1,887 shares
@ $0
Granted 10,173 options to buy
@ $79.45, valued at
$808.2k
|
|
| 05/04/2023 |
4
| Bluestone Jeffrey (Director) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Granted 1,887 restricted stock units
@ $0
Granted 10,173 options to buy
@ $79.45, valued at
$808.2k
|
|
| 05/04/2023 |
4
| Horning Sandra (Director) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Granted 1,887 shares
@ $0
Granted 10,173 options to buy
@ $79.45, valued at
$808.2k
|
|
| 05/04/2023 |
4
| Lofton Kevin E (Director) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Granted 1,887 shares
@ $0
Granted 10,173 options to buy
@ $79.45, valued at
$808.2k
|
|
| 05/04/2023 |
4
| Rodriguez Javier (Director) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Granted 1,887 shares
@ $0
Granted 10,173 options to buy
@ $79.45, valued at
$808.2k
|
|
| 05/04/2023 |
4
| MANWANI HARISH (Director) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Granted 1,887 shares
@ $0
Paid exercise price by delivering 368 shares
@ $79.45, valued at
$29.2k
Granted 10,173 options to buy
@ $79.45, valued at
$808.2k
|
|
| 05/04/2023 |
4
| WELTERS ANTHONY (Director) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Granted 1,887 shares
@ $0
Granted 10,173 options to buy
@ $79.45, valued at
$808.2k
|
|
| 05/02/2023 |
4
| Lofton Kevin E (Director) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Gifted 12,868 shares
@ $0 |
|
| 03/31/2023 |
4
| Lofton Kevin E (Director) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Granted 29 options to buy
@ $0 |
|
| 03/14/2023 |
4
| Parsey Merdad (Chief Medical Officer) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Sold 6,126 shares
@ $78.99, valued at
$483.9k
|
|
| 03/14/2023 |
4
| O'Day Daniel Patrick (Chairman & CEO) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Paid exercise price by delivering 14,017 shares
@ $79.5, valued at
$1.1M
Exercised 19,488 restricted stock units
@ $0
Exercised 10,800 restricted stock units
@ $0
Granted 47,170 restricted stock units
@ $0
Granted 215,095 options to buy
@ $79.5, valued at
$17.1M
|
|
| 03/13/2023 |
4
| Parsey Merdad (Chief Medical Officer) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Paid exercise price by delivering 5,328 shares
@ $79.5, valued at
$423.6k
Exercised 3,455 restricted stock units
@ $0
Exercised 7,999 restricted stock units
@ $0
Granted 16,665 restricted stock units
@ $0
Granted 76,000 options to buy
@ $79.5, valued at
$6M
|
|
| 03/13/2023 |
4
| Patterson Sandra (SVP, Controllership) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Paid exercise price by delivering 801 shares
@ $79.5, valued at
$63.7k
Exercised 1,601 restricted stock units
@ $0
Exercised 1,320 restricted stock units
@ $0
Granted 6,130 restricted stock units
@ $0
Granted 10,405 options to buy
@ $79.5, valued at
$827.2k
|
|
| 03/13/2023 |
4
| Mercier Johanna (Chief Commercial Officer) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Paid exercise price by delivering 5,116 shares
@ $79.5, valued at
$406.7k
Exercised 3,025 restricted stock units
@ $0
Exercised 7,951 restricted stock units
@ $0
Granted 16,350 restricted stock units
@ $0
Granted 74,565 options to buy
@ $79.5, valued at
$5.9M
|
|
| 03/13/2023 |
4
| Dickinson Andrew D (CFO) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Paid exercise price by delivering 4,849 shares
@ $79.5, valued at
$385.5k
Exercised 3,025 restricted stock units
@ $0
Exercised 7,394 restricted stock units
@ $0
Granted 16,350 restricted stock units
@ $0
Granted 74,565 options to buy
@ $79.5, valued at
$5.9M
|
|
| 03/13/2023 |
4
| Telman Deborah H (EVP, Corporate Affairs & GC) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Granted 10,220 restricted stock units
@ $0
Granted 46,605 options to buy
@ $79.5, valued at
$3.7M
|
|
| 03/10/2023 |
4
| Lofton Kevin E (Director) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Exercised 8,442 options to buy
@ $52.38, valued at
$442.2k
|
|
| 03/02/2023 |
4
| Parsey Merdad (Chief Medical Officer) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Sold 12,984 shares
@ $79.9619, valued at
$1M
|
|
| 03/02/2023 |
4
| O'Day Daniel Patrick (Chairman & CEO) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Paid exercise price by delivering 4,842 shares
@ $79.59, valued at
$385.4k
Exercised 11,362 restricted stock units
@ $0 |
|
| 02/23/2023 |
4
| Dickinson Andrew D (CFO) has filed a Form 4 on GILEAD SCIENCES, INC.|
Txns:
| Granted 376 shares
@ $56.3805, valued at
$21.2k
|
|
|
|
|